Summary
Caleb Ellington is a research scientist and computational biologist with a decade of experience applying machine learning and software engineering to precision medicine and therapeutic discovery. Currently at GenBio AI and a PhD candidate in the CMU-PITT Computational Biology program, he builds foundation-model and probabilistic approaches for target identification and rare-disease therapeutics. His background spans deep learning for protein folding at the Institute for Protein Design, ML-driven drug discovery at Genesis Therapeutics, and scalable lab informatics and cloud infrastructure from earlier research and software roles. Equally at home with code and biology, he blends production-ready software practices with cutting-edge probabilistic and multi-task learning methods to move models toward real-world impact. Based in San Francisco, he describes himself succinctly on GitHub as a "Computational Biologer," signaling a pragmatic, research-first approach to computational biology.
11 years of coding experience
4 years of employment as a software developer
B.S., Computer Science, B.S., Computer Science at University of Washington
Doctor of Philosophy - PhD, Computational Biology, Doctor of Philosophy - PhD, Computational Biology at Carnegie Mellon University School of Computer Science